Helio AI | $1,000,000 | (Nov 27, 2025)
Procure Ai | $13,000,000 | (Nov 27, 2025)
Overstory | $43,000,000 | (Nov 27, 2025)
Certified by Founder
Lodge
NeuroSense Therapeutics
start up
United States
- Cambridge, Massachusetts
- 09/12/2021
- Unknown
- $12,000,000
Advancing research, development and therapy for ALS and additional CNS indications.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.
- Industry Biotechnology Research
- Website http://www.neurosense-tx.com/
- LinkedIn https://www.linkedin.com/company/neurosense-therapeutics/about/
Related People
Alon Ben-NoonCo Founder
Israel -
Herzliyya, Tel Aviv
Life Sciences Executive ; Leading NeuroSense Therapeutics, a Biotech startup which accelerates research, development and therapy for ALS (Amyotrophic Lateral Sclerosis) and additional Neurodegenerative diseases.
LinkedIn
https://www.linkedin.com/in/alonbn/
Global Work AI | $2,400,000 | (Nov 27, 2025)
SubImage (YC W25) | $4,200,000 | (Nov 27, 2025)
AUGMENTT | $18,000,000 | (Nov 27, 2025)
EcoG | $18,573,280 | (Nov 27, 2025)
Parallax Worlds | $4,900,000 | (Nov 27, 2025)
CoPlane | $14,000,000 | (Nov 27, 2025)
The Intelligent Search Company (TISC) | $2,100,000 | (Nov 27, 2025)
Redrob | $10,000,000 | (Nov 25, 2025)
Relixir | $2,000,000 | (Nov 25, 2025)